United States Sickle Cell Anaemia Testing Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Market Size and Growth

Sickle Cell Anaemia Testing Market is expected to reach at a high CAGR during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ In October 2025, Terumo Blood and Cell Technologies and Hemex Health announced the expansion of their Gazelle® diagnostic platform, now available in over 40 countries. This portable, low-cost device enables rapid identification of hemoglobin variants, aiding in the diagnosis of sickle cell and beta thalassemia, particularly in resource-limited settings.

✅ In September 2025, Prisma Health launched two new sickle cell clinics in South Carolina, supported by a $2 million state investment. The Sickle Cell Lifespan Center in Greenville and Columbia aims to provide comprehensive care and treatment for sickle cell patients, marking a significant milestone in regional healthcare services.

✅ In September 2025, Hemex Health secured a $2.5 million investment from MedAccess to scale up access to its point-of-care sickle cell diagnostic testing platform in high-burden countries. This funding will support the expansion of Hemex's diagnostic capabilities, improving early detection and treatment of sickle cell disease.

✅ In August 2025, Pfizer announced the results of its Phase 3 THRIVE-131 study evaluating inclacumab, an investigational P-selectin inhibitor, for sickle cell disease. While the study did not meet its primary endpoint, Pfizer remains committed to advancing research and understanding in the sickle cell community.

Japan: Recent Industry Developments

✅ In September 2025, a case of sickle cell retinopathy was reported in Japan, highlighting the onset of retinal artery occlusion as a complication of sickle cell disease. This case underscores the importance of early detection and monitoring for patients with sickle cell disease in Japan.

✅ In 2025, Japan's market for rapid point-of-care testing for sickle cell anemia remained niche due to the low domestic prevalence of the disease. However, multinational companies such as Siemens Healthineers, Roche Diagnostics, and Sysmex are focusing on developing advanced diagnostic tools, including molecular-level POC tests, to enhance early detection capabilities.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/sickle-cell-anaemia-testing-market?sb

Sickle cell anemia testing involves diagnostic methods to detect abnormal hemoglobin (HbS) or genetic mutations causing sickle-shaped red blood cells. Techniques include hemoglobin electrophoresis, solubility tests, and DNA analysis, enabling early diagnosis, carrier detection, and informed treatment decisions.

Key Players:

=> B. Braun Medical Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terumo Europe NV, Becton and Dickinson Company, Zenroxmed Healthcare, Shenzhen Hawk Medical Instrument Co., Ltd (Hawkmed), Baxter, ICU Medical Inc., Micrel Medical Devices SA, and QuadMed, Inc among others.

Growth Forecast Projected:

The Global Sickle Cell Anaemia Testing Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Sickle Cell Anaemia Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=sickle-cell-anaemia-testing-market

Key Segments:

➥ By Test Type: Hemoglobin S Solubility Test and Sodium Metabisulfite Test, Hemoglobinopathy (Hb) Evaluation, Genetic Testing (DNA Analysis), DNA Sequencing, Others
➥ By Product Type: Kits, Reagents
➥ By End-User: Hospitals, Diagnostic Centers, Others

Regional Analysis for Sickle Cell Anaemia Testing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Sickle Cell Anaemia Testing producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Sickle Cell Anaemia Testing revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/sickle-cell-anaemia-testing-market?sb

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.